Two Sigma Investments’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,130
| Closed | -$43.1K | – | 3503 |
|
|
2024
Q3 | $43.1K | Sell |
11,130
-7,815
| -41% | -$30.2K | ﹤0.01% | 2909 |
|
|
2024
Q2 | $44K | Sell |
18,945
-19,872
| -51% | -$46.1K | ﹤0.01% | 2816 |
|
|
2024
Q1 | $109K | Sell |
38,817
-3,802
| -9% | -$10.7K | ﹤0.01% | 2747 |
|
|
2023
Q4 | $136K | Buy |
+42,619
| New | +$136K | ﹤0.01% | 2820 |
|
|
2021
Q2 | – | Sell |
-10,519
| Closed | -$123K | – | 2988 |
|
|
2021
Q1 | $123K | Buy |
+10,519
| New | +$123K | ﹤0.01% | 2215 |
|
|
2020
Q1 | – | Sell |
-37,288
| Closed | -$849K | – | 2497 |
|
|
2019
Q4 | $849K | Buy |
37,288
+1,130
| +3% | +$25.7K | ﹤0.01% | 1479 |
|
|
2019
Q3 | $517K | Sell |
36,158
-12,677
| -26% | -$181K | ﹤0.01% | 1445 |
|
|
2019
Q2 | $650K | Sell |
48,835
-6,423
| -12% | -$85.5K | ﹤0.01% | 1509 |
|
|
2019
Q1 | $960K | Buy |
55,258
+4,785
| +9% | +$83.1K | ﹤0.01% | 1444 |
|
|
2018
Q4 | $690K | Sell |
50,473
-3,215
| -6% | -$44K | ﹤0.01% | 1472 |
|
|
2018
Q3 | $1.16M | Buy |
53,688
+40,598
| +310% | +$873K | ﹤0.01% | 1313 |
|
|
2018
Q2 | $561K | Buy |
+13,090
| New | +$561K | ﹤0.01% | 1598 |
|
|
2018
Q1 | – | Sell |
-4,271
| Closed | -$312K | – | 2417 |
|
|
2017
Q4 | $312K | Buy |
+4,271
| New | +$312K | ﹤0.01% | 1929 |
|
|
2015
Q2 | – | Sell |
-1,143
| Closed | -$563K | – | 2461 |
|
|
2015
Q1 | $563K | Buy |
+1,143
| New | +$563K | ﹤0.01% | 1629 |
|
|
2013
Q3 | – | Sell |
-1,542
| Closed | -$273K | – | 2165 |
|
|
2013
Q2 | $273K | Buy |
+1,542
| New | +$273K | ﹤0.01% | 1674 |
|